Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.

Muir, Ryan T; Ismail, Zahinoor; Black, Sandra E; Smith, Eric E

Muir, Ryan T; Ismail, Zahinoor; Black, Sandra E; Smith, Eric E.

Afiliación

Muir RT; Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Ismail Z; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Black SE; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Smith EE; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Alzheimers Dement ; 20(2): 1436-1458, 2024 Feb.

Article en En | MEDLINE | ID: mdl-37908054

Asunto(s)

Enfermedad de Alzheimer; Angiopatía Amiloide Cerebral; Humanos; Enfermedad de Alzheimer/diagnóstico; Péptidos beta-Amiloides; Angiopatía Amiloide Cerebral/diagnóstico; Inflamación; Biomarcadores

Palabras clave

Alzheimer's disease; amyloid; biomarker; cerebral amyloid angiopathy; cerebrospinal fluid; diagnostic test performance; intracerebral hemorrhage; plasma; tau

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Angiopatía Amiloide Cerebral / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google